Over the last few years, the Middle East has piqued the interest of orphan drug manufacturers, and some have prioritised launching in this region before European markets. Akshay Kumar and Lavni Varyani discuss what is driving this behaviour, the orphan drug infrastructure within the region, and opportunities, barriers, and key considerations for manufacturers aiming to launch in the Middle East.
Presenter: Akshay Kumar, Partner, P4A
Contributor: Lavni Varyani, Founder, Pharma Business Partners
Producer: Operations team
Weekly Roundup: February 28, 2019
Weekly Roundup: February 22, 2019
Weekly Roundup: February 15, 2019
Weekly Roundup: February 1, 2019
Weekly Roundup: January 25, 2019
Weekly Roundup: January 18, 2019
Weekly Roundup: January 11, 2019
Weekly Roundup: December 14, 2018
Weekly Roundup: December 7, 2018
Weekly Roundup: November 30, 2018
Weekly Roundup: November 23, 2018
Weekly Roundup: November 15, 2018
Weekly Roundup: November 9, 2018
Weekly Roundup: November 2, 2018
Weekly Roundup: October 25, 2018
Weekly Roundup: October 18, 2018
Weekly Roundup: October 11, 2018
Weekly Roundup: Oct 5, 2018
Weekly Roundup: Sep 27, 2018
Weekly Roundup: September 20, 2018
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain